Effects of atropine on human cardiac β1- and/or β2-adrenoceptor stimulation

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 367, Issue 6, 2003, Pages 572-577

  Bruck, Heike ^a,b   Ulrich, Anke ^a   Gerlach, Stefan ^a   Radke, Joachim ^a   Brodde, Otto Erich ^a,b  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

Author keywords

Adrenoceptors; Contractility; Heart rate; Human; In vivo; Vagal tone

Indexed keywords

ADRENALIN; ALEUDRINA; ATROPINE; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; ISOPRENALINE; TERBUTALINE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; EXERCISE; HEART MUSCLE CONTRACTILITY; HEART RATE; HEART WORK; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; SYSTOLIC BLOOD PRESSURE; VAGUS TONE;

ADULT; ANALYSIS OF VARIANCE; ATROPINE; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; EPINEPHRINE; HEART RATE; HUMANS; MALE; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2;

EID: 0037966080     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-003-0757-9     Document Type: Article

References (27)

1. Arnold JMO, McDevitt DG (1984) Vagal activity is increased during intravenous isoprenaline infusion in man. Br J Clin Pharmacol 18:311-316
2. 2-adrenoceptor antagonist ICI 118,551 on exercise tachycardia and isoprenaline-induced β-adrenoceptor responses in man. Br J Clin Pharmacol 19:619-630
3. Belz GG (1995) Systolic time intervals: a method to assess cardiovascular drug effects in humans. Eur J Clin Invest 25 [Suppl 1]: 35-41
4. Belz GG, Matthews JH, Graf D, Stern HC, Bachmann R, Belz G, Steinijans VW, Palm D (1985) Dynamic responses to intravenous urapidil and dihydralazine in normal subjects. Clin Pharmacol Ther 37:48-54
5. 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol Rev 43:203-242
6. Brodde O-E, Michel MC (1999) Adrenergic and muscarinic receptors in the human heart. Pharmacol Rev 51:651-689
7. Brodde O-E, Konschak U, Becker K, Rüter F, Poller U, Jakubetz J, Radke J, Zerkowski H-R (1998) Cardiac muscarinic receptors decrease with age. In vitro and in vivo studies. J Clin Invest 101:471-478
8. 2-receptor stimulation by circulating adrenaline. N Engl J Med 309:1414-1419
9. Daul A, Hermes U, Schäfers RF, Wenzel R, von Birgelen C, Brodde O-E (1995) The β-adrenoceptor subtype(s) mediating adrenaline- and dobutamine-induced blood pressure and heart rate changes in healthy volunteers. Int J Clin Pharmacol Ther 32:140-148
10. Deighton NM, Motomura S, Borquez D, Zerkowski H-R, Doetsch N, Brodde O-E (1990) Muscarinic cholinoceptors in the human heart: demonstration, subclassification and distribution. Naunyn-Schmiedebergs Arch Pharmacol 341:14-21
11. Dhein S, Van Koppen CJ, Brodde O-E (2001) Muscarinic receptors in the mammalian heart. Pharmacol Res 44:161-182
12. 2-adrenoceptors in the transplanted human heart. J Cardiovasc Pharmacol 30:811-816
13. 3 receptor subtype gene expression in the human heart. Cell Mol Life Sci 57:175-180
14. Kent KM, Epstein SE, Cooper T, Jacobowitz DM (1974) Cholinergic innervation of the canine and human ventricular conducting system: anatomic and electrophysiologic correlations. Circulation 50:948-955
15. 5 subtypes of muscarinic receptors in rat heart and brain cortex. Mol Pharmacol 61:1267-1272
16. Landzberg JS, Parker JD, Gauthier DE, Colucci WS (1994) Effect of intracoronary acetylcholine and atropine on basal and dobutamine-stimulated left ventricular contractility. Circulation 89:164-168
17. 1 vs non-selective beta-blockade. Clin Pharmacol Ther 43:519-528
18. 2-agonist in humans. Circulation 79:107-115
19. Löffelholz K, Pappano AJ (1985) The parasympathetic neuroeffector junction of the heart. Pharmacol Rev 37:1-24
20. McDevitt DG (1989) In vivo studies of the function of β-adrenoceptors in man. Eur Heart J 10 [Suppl B]:22-28
21. 2 adrenoceptors in the human heart: in vitro and in vivo studies. Am Heart J 119:608-619
22. Newton GE, Parker AB, Landzberg JS, Colucci WS, Parker JD (1996) Muscarinic receptor modulation of basal and β-adrenergic stimulated function of the failing human left ventricle. J Clin Invest 98:2756-2763
23. Oberhauser V, Schwertfeger E, Rutz T, Beyersdorf F, Rump LC (2001) Acetylcholine release in human heart atrium: influence of muscarinic autoreceptors, diabetes and age. Circulation 103:1638-1643
24. Poller U, Nedelka G, Radke J, Pönicke K, Brodde O-E (1997) Age-dependent changes in cardiac muscarinic receptor function in healthy volunteers. J Am Coll Cardiol 29:187-193
25. 1-adrenoceptor antagonist treatment. J Am Coll Cardiol 23:1224-1233
26. Schäfers RF, Poller U, Pönicke K, Geissler M, Daul AE, Michel MC, Brodde O-E (1997) Influence of adrenoceptor and muscarinic receptor blockade on the cardiovascular effects of exogenous noradrenaline and of endogenous noradrenaline released by infused tyramine. Naunyn-Schmiedebergs Arch Pharmacol 355:239-249
27. Stern H, Matthews JH, Belz GG (1984) Influence of dihydralazine induced afterload reduction on systolic time intervals and echocardiography in healthy subjects. Br Heart J 52:435-439